Can-Fite BioPharma Ltd.CANFNYSE
Loading
P/E Ratio: Premium ValuationElevated
Percentile Rank86
Year-over-Year Change
Price-to-earnings ratio
Latest
-4320.26
↑ 50% vs avg
Percentile
P86
Within normal range
Streak
1 yr
Consecutive declineElevated
Average
-8612.34
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2024 | -4320.26 | -15.8% |
| 2023 | -3732.29 | +26.2% |
| 2022 | -5059.00 | +2.2% |
| 2021 | -5170.70 | -17.8% |
| 2020 | -4390.41 | -98.9% |
| 2019 | -2206.80 | +80.0% |
| 2018 | -11011.89 | +23.9% |
| 2017 | -14473.21 | +0.8% |
| 2016 | -14582.80 | +31.1% |
| 2015 | -21176.03 | - |